Lymphoma And Weight
Published on: May 25, 2025
Lymphoma and Weight featured image
Written By: Laura Khosravi
Author:
Laura Khosravi BSc Pharmacology and Innovative Therapeutics with honours, Queen Mary University of London
Reviewed by:
Husnaa Shams BSc Medical Science, University of Reading
Tajwar Khatoon Mphil in Pharmaceutical Sciences from KUST, Kohat, Pakistan

Introduction

Lymphoma, a form of cancer that affects the lymphatic system, has a substantial influence on a patient's life, particularly their weight. Whether an increase or a decrease, weight fluctuations can be both a sign of the disease and a side effect of treatment. Understanding the association between lymphoma and weight is critical for patients, carers, and healthcare professionals seeking to manage the disease and uphold overall health.

What is lymphoma?

Lymphoma develops in the lymphatic system and is an important component of the immune system that aids the body in attacking infections and clearing waste. This system consists of lymph nodes, lymphatic tubes, spleen, thymus gland, and bone marrow. It is essential for the circulation of lymph, a fluid that contains white blood cells that target and eliminate infections. Lymphoma develops when aberrant lymphocytes (a kind of white blood cell) proliferate excessively and form tumours in lymphatic tissue.1

Lymphoma is widely divided into two types: Hodgkin lymphoma (HL) and non-Hodgkin lymphoma. These groups differ in terms of cell origin, illness development, prognosis, and therapy options. Reed-Sternberg cells, massive aberrant lymphocytes, are not observed in non-Hodgkin lymphomas, which differentiates Hodgkin lymphoma from other forms. HL has a more predictable pattern of dissemination, frequently beginning in a single group of lymph nodes and progressing in an organised manner. It primarily affects young adults and anyone over the age of 55, and it is largely curable, particularly when discovered early.

Non-Hodgkin lymphoma, on the other hand, is far more complex, with over 60 subtypes, which include diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma. NHL can develop from either B or T cells, and its growth rate can range from slow to aggressive. Because of this variety, treatment plans are more personalised and may involve a mix of chemotherapy, radiation, targeted treatments, and immunotherapy.

Lymphoma can occur at any age, and risk factors include immunological suppression, particular infections (e.g., Epstein-Barr virus, HIV), and environmental exposure. Regardless of form, both HL and NHL can impair immune function and cause systemic symptoms such as exhaustion, fevers, night sweats, and unexplained weight loss, commonly known as "B symptoms," which may signal a more advanced or aggressive illness.

Why does weight loss occur?

Unintentional weight loss is a common early warning indication of lymphoma. This weight loss is commonly characterised as losing more than 10% of body weight over six months without effort, a condition known as "B symptoms" in lymphoma categorisation, which also includes fever and night sweats.

This weight loss is not the result of lifestyle changes or diets, but of the cancer's metabolic influence on the body. Tumours frequently absorb a considerable portion of the body's energy, and the inflammatory reaction caused by the malignancy can boost metabolism, resulting in muscle atrophy and fat loss. In addition, nausea, weariness, or overall illness can all cause appetite loss.1,2 

Weight loss mechanism in Lymphoma

There are several mechanisms through which lymphoma causes weight loss:

  1. Hypermetabolism: Cancer cells frequently consume glucose at a rapid pace, resulting in a catabolic state in which the body tears down muscle and fat for energy 
  2. Lymphoma cells and the immune system produce cytokines, including TNF-α and interleukins, which are linked to cachexia (muscle and weight loss) 
  3. Loss of appetite: Fatigue, nausea, or the psychological effects of the disease may restrict food intake, adding to additional weight loss3,4

Weight gain during and after treatment

In contrast to pre-diagnosis weight loss, weight gain is typical during and after lymphoma treatment, especially in individuals receiving chemotherapy or corticosteroid therapy. A variety of causes can contribute to weight increase, including:

  • Increased appetite due to steroids (e.g., prednisone)
  • Reduced physical activity
  • Hormonal changes
  • Fluid retention
  • Psychological coping mechanisms like emotional eating1,2

The impact of weight changes on prognosis

Weight changes in lymphoma patients are more than cosmetic, they can affect treatment outcomes, quality of life, and long-term health.

Unintentional weight reduction before diagnosis is frequently connected with a more aggressive illness and an adverse prognosis. It might show a large tumour load or systemic involvement. Cachexia is also linked with decreased treatment tolerance and an increase in treatment-related problems.4,5

Nutritional management during lymphoma treatment

Nutrition is critical for managing weight fluctuations in lymphoma patients. Depending on the patient's demands, tailored dietary techniques can aid with weight reduction or weight gain control. For patients experiencing weight loss, high-calorie and high-protein meals can help keep lean muscle mass and improve immunological function. Small, frequent meals may be more palatable than huge meals. Nutritional supplements (e.g., smoothies, protein powders) might be beneficial when appetite is low.

For patients gaining weight, balanced meals with restricted quantities and low sugar and fat content can help avoid excessive weight gain. Regular physical exercise, as tolerated, should be encouraged to preserve muscle mass and metabolic health. Behavioural counselling can assist with emotional eating and steroid-induced cravings.6,7

Psychological aspects of weight changes

The emotional toll of cancer, along with abrupt shifts in physical appearance owing to weight fluctuations, might lead to discomfort, melancholy, or anxiety. Body image issues are frequent, especially in younger patients or individuals going through fast weight fluctuations. Addressing psychological issues through counselling, support groups, or treatment is just as vital as addressing physical problems. Encourage self-compassion and emphasise rehabilitation above appearance to assist patients in coping more successfully.8,9

Long-term survivorship and weight management

As therapy completes and patients reach remission, the emphasis frequently switches from acute care to long-term health management. However, for many lymphoma survivors, weight-related difficulties continue even after treatment has ended. Studies have revealed that survivors are more likely to develop metabolic syndrome, which includes hypertension, insulin resistance, and abnormal cholesterol levels. These difficulties can be exacerbated by the long-term effects of chemotherapy, corticosteroids, and decreased physical activity during treatment. 

Maintaining a healthy weight after treatment is more crucial than simply appearance; it's about avoiding chronic diseases that might reduce quality of life or raise the risk of subsequent malignancies. Regular follow-ups should include evaluations of body composition, cardiovascular health, and dietary condition. Interventions conducted by dietitians and physiotherapists can be very beneficial in developing personalised strategies that promote recovery while addressing weight objectives. Structured exercise programs, including mild activities such as walking, yoga, or low-impact resistance training, can help rebuild lost muscle, improve mood, and promote general well-being. At the same time, emotional support and education on good eating habits contribute to long-term behavioural adjustments.

Weight management should be a fundamental component of survivorship care plans, ensuring that patients are supported not just during remission but also after treatment by maintaining a sustainable and healthy lifestyle. This comprehensive strategy enables individuals to take control of their health while lowering the chance of future issues.10,11,12

Summary

Weight changes in lymphoma patients are complicated and nuanced. While weight loss can be an early sign of the condition, weight gain is frequently a side effect of therapy. Both extremes can have a substantial impact on a patient's health, rehabilitation, and quality of life. A comprehensive, patient-centred strategy that combines dietary counselling, physical exercise, psychological support, and frequent medical monitoring is critical for weight management throughout the cancer journey, from diagnosis to survival. Patients with lymphoma can improve their results, improve their quality of life, and navigate the road to recovery by treating both the physical and emotional components of their weight.

References 

  1. Jamil A, Mukkamalla SKR. Lymphoma. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560826/
  2. Lewis WD, Lilly S, Jones KL. Lymphoma: Diagnosis and Treatment. Am Fam Physician. 2020 Jan 1;101(1):34-41. PMID: 31894937.
  3. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev. 2009 Apr;89(2):381-410. doi: 10.1152/physrev.00016.2008. PMID: 19342610.
  4. Argilés JM, Busquets S, Stemmler B, López-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014 Nov;14(11):754-62. doi: 10.1038/nrc3829. Epub 2014 Oct 9. PMID: 25291291.
  5. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008 Jul 24;454(7203):436-44. doi: 10.1038/nature07205. PMID: 18650914.
  6. Laviano A, Meguid MM, Inui A, Muscaritoli M, Rossi-Fanelli F. Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself. Nat Clin Pract Oncol. 2005 Mar;2(3):158-65. doi: 10.1038/ncponc0112. PMID: 16264909.
  7. Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hütterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Mühlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017 Feb;36(1):11-48. doi: 10.1016/j.clnu.2016.07.015. Epub 2016 Aug 6. PMID: 27637832.
  8. Ali J, Siddiqui N, Hameed A. Weight Changes In Patients With Hodgkin Lymphoma Following Treatment: Experience From A Cancer Hospital. J Ayub Med Coll Abbottabad. 2016 Oct-Dec;28(4):738-741. PMID: 28586610.
  9. Chin YH, Liu JM, Tai JJ, Chuang MS, Ho YL, Chen YM, Whang-Peng J, Cheng AL. The significance of body weight change in non-Hodgkin lymphoma. Anticancer Res. 1999 Nov-Dec;19(6C):5607-10. PMID: 10697626.
  10. Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, Bandera EV, Hamilton KK, Grant B, McCullough M, Byers T, Gansler T. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012 Jul-Aug;62(4):243-74. doi: 10.3322/caac.21142. Epub 2012 Apr 26. Erratum in: CA Cancer J Clin. 2013 May;63(3):215. PMID: 22539238.
  11. Fingeret MC, Teo I, Epner DE. Managing body image difficulties of adult cancer patients: lessons from available research. Cancer. 2014 Mar 1;120(5):633-41. doi: 10.1002/cncr.28469. Epub 2013 Nov 21. PMID: 24895287; PMCID: PMC4052456.
  12. Demark-Wahnefried W, Schmitz KH, Alfano CM, Bail JR, Goodwin PJ, Thomson CA, Bradley DW, Courneya KS, Befort CA, Denlinger CS, Ligibel JA, Dietz WH, Stolley MR, Irwin ML, Bamman MM, Apovian CM, Pinto BM, Wolin KY, Ballard RM, Dannenberg AJ, Eakin EG, Longjohn MM, Raffa SD, Adams-Campbell LL, Buzaglo JS, Nass SJ, Massetti GM, Balogh EP, Kraft ES, Parekh AK, Sanghavi DM, Morris GS, Basen-Engquist K. Weight management and physical activity throughout the cancer care continuum. CA Cancer J Clin. 2018 Jan;68(1):64-89. doi: 10.3322/caac.21441. Epub 2017 Nov 22. Erratum in: CA Cancer J Clin. 2018 May;68(3):232. doi: 10.3322/caac.21449. PMID: 29165798; PMCID: PMC5766382.
Share

Laura Khosravi

BSc Pharmacology and Innovative Therapeutics with honours, Queen Mary University of London

arrow-right